Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter




Read in Swedish

Vitrolife AB (publ): Vitrolife appoints Patrik Tolf as new CFO

08:30 / 21 October 2021 Vitrolife Press release

Patrik Tolf has been appointed new CFO of Vitrolife AB (publ) effective 1 January 2022. Patrik is currently interim CFO at Karolinska University Hospital. Patrik is 51 years old and holds a master's degree in business administration and has previously held senior finance positions within Volvo Car Group and Saab AB (publ).

"We are pleased to welcome Patrik Tolf to Vitrolife and our executive management team and we look forward to benefiting from Patrik's broad operational and strategic experience in the company's continued growth journey," says Thomas Axelsson, CEO.

Patrik Tolf replaces Mikael Engblom who remains CFO until Patrik takes office.

Gothenburg, October 21, 2021
Thomas Axelsson, CEO


Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail:

Show as PDF

Show original from Cision


This information was distributed by Cision